A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease Post author: Post published:March 1, 2026 Post category: Continue ReadingA Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease
Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR) Post author: Post published:March 1, 2026 Post category: Continue ReadingDose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)
Phase 1/2a Study of ANPD001 in Parkinson Disease Post author: Post published:March 1, 2026 Post category: Continue ReadingPhase 1/2a Study of ANPD001 in Parkinson Disease
Continued Evaluation of Patients With Parkinson’s Disease Who Previously Received BRT-DA01 Post author: Post published:March 1, 2026 Post category: Continue ReadingContinued Evaluation of Patients With Parkinson’s Disease Who Previously Received BRT-DA01
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER) Post author: Post published:March 1, 2026 Post category: Continue ReadingCRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
